UPDATE: Credit Suisse Starts Salix Pharmaceuticals (SLXP) at Underperform; Allergan Deal Unlikely, Says Analyst
Tweet Send to a Friend
(Updated - September 12, 2014 11:28 AM EDT)
Credit Suisse initiated coverage on Salix Pharmaceuticals (NASDAQ: SLXP) with an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Credit Suisse initiated coverage on Salix Pharmaceuticals (NASDAQ: SLXP) with an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
